Anaerobic digestion of screenings for biogas recovery

Screenings comprise untreatable solid materials that have found their way into the sewer. They are removed during preliminary treatment at the inlet work of any wastewater treatment process using a unit operation termed as a screen and at present are disposed of to landfill. These materials, if not removed, will damage mechanical equipment due to its heterogeneity and reduce overall treatment process, reliability and effectiveness. That is why this material is retained and prevented from entering the treatment system before finally being disposed of. The amount of biodegradable organic matter in screenings often exceeds the upper limit and emits a significant amount of greenhouse gases during biodegradation on landfill. Nutrient release can cause a serious problem of eutrophication phenomena in receiving waters and a deterioration of water quality. Disposal of screenings on landfill also can cause odour problem due to putrescible nature of some of the solid material. In view of the high organic content of screenings, anaerobic digestion method may not only offer the potential for energy recovery but also nutrient. In this study, the anaerobic digestion was performed for 30,days, at controlled pH and temperature, using different dry solids concentrations of screenings to study the potential of biogas recovery in the form of methane. It was found screenings have physical characteristics of 30% total solids and 93% volatile solids, suggesting screenings are a type of waste with high dry solids and organic contents. Consistent pH around pH 6.22 indicates anaerobic digestion of screenings needs minimum pH correction. The biomethane potential tests demonstrated screenings were amenable to anaerobic digestion with methane yield of 355,m3/kg VS, which is comparable to the previous results. This study shows that anaerobic digestion is not only beneficial for waste treatment but also to turn waste into useful resources

Oxygen uptake kinetics in trained adolescent females

Little evidence exists with regard to the effect that exercise training has upon oxygen uptake kinetics in adolescent females. PURPOSE: The aim of the study was to compare [Formula: see text] and muscle deoxygenation kinetics in a group of trained (Tr) and untrained (Utr) female adolescents. METHOD: Twelve trained (6.4 ± 0.9 years training, 10.3 ± 1.4 months per year training, 5.2 ± 2.0 h per week) adolescent female soccer players (age 14.6 ± 0.7 years) were compared to a group (n = 8) of recreationally active adolescent girls (age 15.1 ± 0.6 years) of similar maturity status. Subjects underwent two, 6-min exercise transitions at a workload equivalent to 80 % of lactate threshold from a 3-min baseline of 10 W. All subjects had a passive rest period of 1 h between each square-wave transition. Breath-by-breath oxygen uptake and muscle deoxygenation were measured throughout and were modelled via a mono-exponential decay with a delay relative to the start of exercise. RESULT: Peak [Formula: see text] was significantly (p < 0.05) greater in the Tr compared to the Utr (Tr: 43.2 ± 3.2 mL kg(-1 )min(-1) vs. Utr: 34.6 ± 4.0 mL kg(-1 )min(-1)). The [Formula: see text] time constant was significantly (p < 0.05) faster in the Tr compared to the Utr (Tr: 26.3 ± 6.9 s vs. Utr: 35.1 ± 11.5 s). There was no inter-group difference in the time constant for muscle deoxygenation kinetics (Tr: 8.5 ± 3.0 s vs. Utr: 12.4 ± 8.3 s); a large effect size, however, was demonstrated (-0.804). CONCLUSION: Exercise training and/or genetic self-selection results in faster kinetics in trained adolescent females. The faster [Formula: see text] kinetics seen in the trained group may result from enhanced muscle oxygen utilisation

MPP+-induced cytotoxicity in neuroblastoma cells: Antagonism and reversal by guanosine

Guanosine exerts neuroprotective effects in the central nervous system. Apoptosis, a morphological form of programmed cell death, is implicated in the pathophysiology of Parkinson’s disease (PD). MPP+, a dopaminergic neurotoxin, produces in vivo and in vitro cellular changes characteristic of PD, such as cytotoxicity, resulting in apoptosis. Undifferentiated human SH-SY5Y neuroblastoma cells had been used as an in vitro model of Parkinson’s disease. We investigated if extracellular guanosine affected MPP+-induced cytotoxicity and examined the molecular mechanisms mediating its effects. Exposure of neuroblastoma cells to MPP+ (10 μM–5 mM for 24–72 h) induced DNA fragmentation in a time-dependent manner (p < 0.05). Administration of guanosine (100 μM) before, concomitantly with or, importantly, after the addition of MPP+ abolished MPP+-induced DNA fragmentation. Addition of MPP+ (500 μM) to cells increased caspase-3 activity over 72 h (p < 0.05), and this was abolished by pre- or co-treatment with guanosine. Exposure of cells to pertussis toxin prior to MPP+ eliminated the anti-apoptotic effect of guanosine, indicating that this effect is dependent on a Gi protein-coupled receptor, most likely the putative guanosine receptor. The protection by guanosine was also abolished by the selective inhibitor of the enzyme PI-3-K/Akt/PKB (LY294002), confirming that this pathway plays a decisive role in this effect of guanosine. Neither MPP+ nor guanosine had any significant effect on α-synuclein expression. Thus, guanosine antagonizes and reverses MPP+-induced cytotoxicity of neuroblastoma cells via activation of the cell survival pathway, PI-3-K/Akt/PKB. Our results suggest that guanosine may be an effective pharmacological intervention in PD

Effect of a web-based chronic disease management system on asthma control and health-related quality of life: study protocol for a randomized controlled trial

<p>Abstract</p> <p>Background</p> <p>Asthma is a prevalent and costly disease resulting in reduced quality of life for a large proportion of individuals. Effective patient self-management is critical for improving health outcomes. However, key aspects of self-management such as self-monitoring of behaviours and symptoms, coupled with regular feedback from the health care team, are rarely addressed or integrated into ongoing care. Health information technology (HIT) provides unique opportunities to facilitate this by providing a means for two way communication and exchange of information between the patient and care team, and access to their health information, presented in personalized ways that can alert them when there is a need for action. The objective of this study is to evaluate the acceptability and efficacy of using a web-based self-management system, My Asthma Portal (MAP), linked to a case-management system on asthma control, and asthma health-related quality of life.</p> <p>Methods</p> <p>The trial is a parallel multi-centered 2-arm pilot randomized controlled trial. Participants are randomly assigned to one of two conditions: a) MAP and usual care; or b) usual care alone. Individuals will be included if they are between 18 and 70, have a confirmed asthma diagnosis, and their asthma is classified as not well controlled by their physician. Asthma control will be evaluated by calculating the amount of fast acting beta agonists recorded as dispensed in the provincial drug database, and asthma quality of life using the Mini Asthma Related Quality of Life Questionnaire. Power calculations indicated a needed total sample size of 80 subjects. Data are collected at baseline, 3, 6, and 9 months post randomization. Recruitment started in March 2010 and the inclusion of patients in the trial in June 2010.</p> <p>Discussion</p> <p>Self-management support from the care team is critical for improving chronic disease outcomes. Given the high volume of patients and time constraints during clinical visits, primary care physicians have limited time to teach and reinforce use of proven self-management strategies. HIT has the potential to provide clinicians and a large number of patients with tools to support health behaviour change.</p> <p>Trial Registration</p> <p>Current Controlled Trials <a href="http://www.controlled-trials.com/ISRCTN34326236">ISRCTN34326236</a>.</p

Zero-lift drag characteristics of afterbodies with a square base

Results of zero-lift drag characteristics of afterbodies with a square base relevant to missile and projectile applications at several transonic Mach numbers and Mach 2 are presented. These afterbodies, at zero incidence, generate vortical flows upstream of the base like that on the lee side of a delta wing at incidence. The measurements made consisted primarily of afterbody drag using a balance and base pressure and extensive surface flow visualization studies were carried out to infer features associated with vortex flows. Results of base pressure, boat-tail profile drag, and total afterbody drag are presented and compared with results from the axisymmetric counterpart involving circular arc and conical boat tailing having the same base area. Some aspects of the flow features on square-base afterbodies are discussed as well

Performance of passive devices for axisymmetric base drag reduction at mach 2

Experiments have been made to assess the effectiveness of passive devices for reducing base and total afterbody drag at Mach 2. The devices examined include primarily base cavities and ventilated cavities. Results show that ventilated cavities offer significant base drag reduction and net drag reduction of engineering value. A correlation for base and net drag reduction for ventilated cavities has been suggested